Zobrazeno 1 - 10
of 155
pro vyhledávání: '"A L Petzer"'
Autor:
Hans Geinitz, Carsten Nieder, Lukas Kocik, Christine Track, Johann Feichtinger, Theresa Weingartner, Kurt Spiegl, Barbara Füreder-Kitzmüller, Johanna Kaufmann, Dietmar H. Seewald, Reinhold Függer, Andreas Shamiyeh, Andreas L. Petzer, David Kiesl, Josef Hammer
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-9 (2020)
Abstract Purpose To report the long-term outcomes of neoadjuvant altered fractionation short-course radiotherapy in 271 consecutive patients with stage II-III rectal cancer. Patients and Methods: This was a retrospective single institution study with
Externí odkaz:
https://doaj.org/article/82faf28c0ab24d36943d95310f80ca2f
Autor:
Paul Sevelda, Marija Balic, Raimund Jakesz, Rupert Bartsch, Margaretha Rudas, Zsuzsanna Bago-Horvath, Martin Filipits, Georg Pfeiler, Angelika Pichler, Sophie Frantal, Austrian Breast, Christoph Tinchon, Florian Fitzal, Tea Maria Muy-Kheng, Vesna Bjelic-Radisic, Herbert Stoeger, Andreas L. Petzer, Peter Dubsky, Christian F. Singer, Edgar Petru, Ruth Exner, Richard Greil, Viktor Wette, Daniel Egle, Michael Hubalek, Michael Gnant
Publikováno v:
British Journal of Cancer. 124:1795-1802
Background Preoperative chemotherapy containing anthracyclines and taxanes is well established in early-stage breast cancer. Previous studies have suggested that the chemotherapy sequence may matter but definitive evidence is missing. ABCSG trial 34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90129e83226f43ed5ddb27c64d0cf30d
https://doi.org/10.1038/s41416-021-01284-2
https://doi.org/10.1038/s41416-021-01284-2
Autor:
Margit Sandholzer, August Zabernigg, Florian Roitner, Daniel Egle, Michael Knauer, Richard Greil, Sonja Heibl, Christoph Tinchon, Daniela Voskova, Michael Hubalek, Gabriel Rinnerthaler, Andreas L. Petzer, Christoph Suppan, Johannes Andel, Simon Peter Gampenrieder, Christian F. Singer
Publikováno v:
Cancer Research. 81:PS12-21
Background: International guidelines recommend endocrine-based first-line therapy [ET] in hormone receptor-positive, HER2-negative (HR+/HER2- or luminal) metastatic breast cancer (MBC), nowadays in combination with a CDK4/6 inhibitor. Several real-wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a76308387e2dd357e188a5db501d998e
https://doi.org/10.1158/1538-7445.sabcs20-ps12-21
https://doi.org/10.1158/1538-7445.sabcs20-ps12-21
Autor:
Michael Knauer, Gabriel Rinnerthaler, Sonja Heibl, Simon P. Gampenrieder, Richard Greil, Johannes Andel, August Zabernigg, Andreas L. Petzer, Christoph Suppan, Margit Sandholzer, Christian F. Singer, Daniel Egle, Daniela Voskova, Christoph Tinchon, Florian Roitner, Michael Hubalek
Publikováno v:
Cancer Research. 81:PS1-41
Background: Metastatic breast cancer (MBC) is generally thought to be a systemic and incurable disease requiring systemic therapy. However, surgical resection of oligometastatic disease might be of benefit similar to other malignant diseases. Here, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::911e483d132a7adf07af456c23266fc7
https://doi.org/10.1158/1538-7445.sabcs20-ps1-41
https://doi.org/10.1158/1538-7445.sabcs20-ps1-41
Autor:
Marie-Luise Hütter-Krönke, Axel Benner, Konstanze Döhner, Jürgen Krauter, Daniela Weber, Margit Moessner, Claus-Henning Köhne, Heinz A. Horst, Ingo G.H. Schmidt-Wolf, Mathias Rummel, Katharina Götze, Elisabeth Koller, Andreas L. Petzer, Hans Salwender, Walter Fiedler, Heinz Kirchen, Detlef Haase, Stephan Kremers, Matthias Theobald, Axel C. Matzdorff, Arnold Ganser, Hartmut Döhner, Richard F. Schlenk
Publikováno v:
Haematologica, Vol 101, Iss 7 (2016)
Outcome of patients with primary refractory acute myeloid leukemia remains unsatisfactory. We conducted a prospective phase II clinical trial with gemtuzumab ozogamicin (3 mg/m2 intravenously on day 1), all-trans retinoic acid (45 mg/m2 orally on day
Externí odkaz:
https://doaj.org/article/e94817aacaec41859b402566beb720a7
Autor:
Thomas Melchardt, Thamer Sliwa, Veronika Buxhofer-Ausch, Heinz Gisslinger, Sonja Heibl, Andreas L. Petzer, Klaus Geissler, Peter Krippl, Christine Beham-Schmid, Dominik Wolf, Albert Wölfler, Maria Theresa Krauth
Publikováno v:
Wiener klinische Wochenschrift. 133:52-61
According to the World Health Organization (WHO) classification, essential (primary) thrombocythemia (ET) is one of several Bcr-Abl negative chronic myeloproliferative neoplasms (MPN). The classical term MPN covers the subcategories of MPN: ET, polyc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5717a77d4c5434a4026f58b860c91ff
https://doi.org/10.1007/s00508-020-01761-3
https://doi.org/10.1007/s00508-020-01761-3
Autor:
Katja Weisel, David Berry, Eberhard Gunsilius, Bela Hausmann, Niklas Zojer, Andreas L. Petzer, Martin Schreder, Daniel Lechner, Richard Greil, Stefan Knop, Karl Jochen Krenosz, Hermann Einsele, Heinz Ludwig, Alois Lang, Roman Hájek, Wolfram Pönisch, Alexander Egle
Publikováno v:
eJHaem. 2:99-103
Alterations in the human microbiome have been linked to several malignant diseases. Here, we investigated the oral microbiome of 79 patients with relapsed/refractory multiple myeloma (MM) treated with ixazomib-thalidomide-dexamethasone. Increased alp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa70ce9f0d4f2306fa1c05eacf7bb3e8
https://doi.org/10.1002/jha2.130
https://doi.org/10.1002/jha2.130
Autor:
Werner Langsteger, Ruth Helfgott, Maria Mascherbauer, Florian Fitzal, Sotiria Theodosiadi, Paul Schlagnitweit, Klaus Emmanuel, Hans Geinitz, Andreas L. Petzer
Publikováno v:
European Journal of Surgical Oncology. 46:1477-1483
Introduction Morbidity after breast cancer surgery remains low with revision surgery below 5%. This retrospective monocentric study investigates whether new methods like neoadjuvant chemotherapy (nCT), oncoplastic surgery (OPS) or intraoperative radi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::728f22d0622fedf188b7335e59e6d47d
https://doi.org/10.1016/j.ejso.2020.04.034
https://doi.org/10.1016/j.ejso.2020.04.034
Autor:
Ralf Kronenwett, Stephanie Meek, Richard Greil, Marija Balic, Austrian Breast, Angelika Pichler, Andreas L. Petzer, Viktor Wette, Zsuzsanna Bago-Horvath, Martin Filipits, Edgar Petru, Margaretha Rudas, Daniel Egle, Christian F. Singer, Peter Dubsky, Christian Fesl, Michael Gnant
Publikováno v:
European Journal of Cancer. 134:99-106
Background Neoadjuvant chemotherapy (NaCT) and neoadjuvant endocrine therapy (NET) can reduce pre-operative tumour burden in patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative early-stage breast ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa5d4cfc6c08c8bbb9590202e6679c5c
https://doi.org/10.1016/j.ejca.2020.04.020
https://doi.org/10.1016/j.ejca.2020.04.020
Autor:
Andreas L. Petzer
Publikováno v:
memo - Magazine of European Medical Oncology. 13:276-279
The recent American Society of Hematology (ASH) annual meeting, held in Orlando, Florida, in December 2019 was an exciting meeting for researchers and clinicians working in the field of chronic myeloid leukemia (CML), as well as for patients sufferin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::158b9886986987d01c04cf95e66bf03b
https://doi.org/10.1007/s12254-020-00616-x
https://doi.org/10.1007/s12254-020-00616-x